2026. INFLUENCE OF COMBINED HYPOLYPIDEMIC THERAPY ON ACHIEVING TARGETED LDL LEVELS IN PATIENTS WITH IBS AND TYPE 2 DIABETES. Web of Teachers: Inderscience Research . 4, 4 (Apr. 2026), 112–114.